Drug
Pegfilgrastim
Pegfilgrastim: highest development phase Phase 3, developed by BeyondSpring. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BeyondSpring
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pegfilgrastim NCT03294577 | Phase 3 | Chemotherapy-induced Neutropenia |
Latest
No recent events.
Follow Pegfilgrastim on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.